{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"Correlation to be determined upon completion of study treatment","groups":[{"description":"Pomalidomide: Comparison of different dosages and schedules of drug","id":"OG000","title":"Pomalidomide 2 mg/d on 28 Days/28 Day Cycle"},{"description":"Pomalidomide: Comparison of different dosages and schedules of drug","id":"OG001","title":"Pomalidomide 4 mg/d on 21 Days/28 Day Cycle"}],"populationDescription":"N/A: data were not collected on this outcome; initial F actin polymerization assay was unreliable and not reproducible; hence, this outcome could not be pursued.","reportingStatus":"POSTED","timeFrame":"Research blood draw will be obtained at baseline, and at 2-4 hr (on day 1), 1 wk, and 4 wk after initiation of cycles 1 and 2.","title":"To Compare the Effect of Continuous Versus Intermittent Regimens on F Actin Polymerization in Peripheral Blood Mononuclear Cells and Activation of Tumor Antigen-specific T Cells, as Well as Innate Lymphocytes (Natural Killer or Natural Killer T Cells).","type":"SECONDARY"}